Polyclonal gammopathy: Difference between revisions
Ttenbergen (talk | contribs) m Text replacement - "== Related CCI Codes ==" to "== Related CCI Codes ==" |
Ttenbergen (talk | contribs) m adding {{Data Integrity Check List}} |
||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
{{ICD10 transition status | {{ICD10 transition status | ||
| OldDxArticle = | | OldDxArticle =Hematology Other | ||
| CurrentStatus = | | CurrentStatus = reconciled | ||
| InitialEditorAssigned = Elaine Nagy | | InitialEditorAssigned = Elaine Nagy | ||
}} | }} | ||
| Line 12: | Line 12: | ||
== Additional Info == | == Additional Info == | ||
Polyclonal gammopathy is a hypergammaglobulinemia, which results from an increased production of several different immunoglobulins. Infectious, inflammatory or various reactive processes may be associated with a broad-based peak or band in the gamma region in serum protein electrophoresis | |||
*Hypergammaglobulinemia results from the overproduction of immunoglobulins by several plasma cell lines1). Monoclonal gammopathy represents single plasma cell activation and is usually associated with several malignant diseases, including multiple myeloma, primary systemic amyloidosis, and other lymphoproliferative disorders1). In contrast, polyclonal gammopathy represents the diffuse activation of B cells, and is associated with a heterogeneous group of nonmalignant conditions, including inflammation and immune-related diseases | |||
== Alternate ICD10s to consider coding instead or in addition == | == Alternate ICD10s to consider coding instead or in addition == | ||
*[Monoclonal gammopathy of undetermined significance (MGUS)] | |||
== Candidate [[Combined ICD10 codes]] == | == Candidate [[Combined ICD10 codes]] == | ||
== Related CCI Codes == | |||
{{Data Integrity Check List}} | |||
== Related Articles == | == Related Articles == | ||
{{Related Articles}} | {{Related Articles}} | ||
{{ICD10 footer}} | {{ICD10 footer}} | ||
{{EndPlaceHolder}} | {{EndPlaceHolder}} | ||